Soraya, Hamid <br/><br/>
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction.  [electronic resource] 

 -  European journal of pharmacology  Aug 2014 
 - 77-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2014.05.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Animals<br/>Hemodynamics--drug effects<br/>Interleukin-6--blood<br/>Isoproterenol--adverse effects<br/>Male<br/>Metformin--pharmacology<br/>Myeloid Differentiation Factor 88--metabolism<br/>Myocardial Infarction--chemically induced<br/>Myocardium--metabolism<br/>Phosphorylation--drug effects<br/>RNA, Messenger--genetics<br/>Rats<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Toll-Like Receptor 4--genetics<br/>Tumor Necrosis Factor-alpha--blood<br/>Ventricular Dysfunction, Left--drug therapy